Trust Asset Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Trust Asset Management's BIIB Position: Q3 2026 in Review
Trust Asset Management held its Biogen (BIIB) position steady in Q3 2026 at 1,617 shares worth $365K. The position accounts for 0.02% of the portfolio, ranked #181.
Trust Asset Management first reported a position in BIIB in Q3 2020 and has held it in 25 quarters since. The position peaked at $503K in Q2 2021. 1,059 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.
- Trust Asset Management held 1,617 shares of Biogen worth $365K as of Q3 2026.
- Trust Asset Management left its Biogen share count unchanged in Q3 2026.
- Biogen made up 0.02% of Trust Asset Management's portfolio in Q3 2026, its #181 holding.
- Trust Asset Management first reported a position in Biogen in Q3 2020 and has held it in 25 quarters since.
- Trust Asset Management's Biogen position peaked at $503K in Q2 2021.
- 1,059 funds tracked by Wall St. Rank held Biogen as of Q3 2026.
Based on Trust Asset Management's 13F filing for Q3 2026, filed 3 Nov 2026.